Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

CategoryBioTech
Phone(415) 994-6455
Employees
Founded2012

Offices

SAN FRANCISCO, USA
45 JUNIPER STREET
SAN FRANCISCO, CA, 94103
USA

Funding

TOTAL $14M
FUNDING TOTAL $14M
Series A, 7/2013
$14M

Tags

Amphivena Therapeutics

Amphivena Therapeutics Inc., a newly created subsidiary of venture-backed Affimed Therapeutics AG , has raised $14 million in Series A financing and has granted Janssen Biotech an exclusive option to acquire the company.

Affimed has used its TandAb technology to develop a pipeline of treatments for diseases such as Hodgkin lymphoma and non-Hodgkin lymphoma. Its new subsidiary, Amphivena, will use this technology to address hematologic malignancies, but specifics about its drug program and the indications it will pursue haven’t been disclosed….

Recent Milestones

Videos

Screenshots

Sources

  1. Affimed Subsidiary Amphivena Raises $14M, Signs Deal With Janssen Biotech (pevc.dowjones.com) [edit]
Edit This Page
Last Edited 7/28/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy